Biofilm-Based Immobilization Fermentation for Continuous hEGF Production in Saccharomyces cerevisiae

Biofilms can enhance industrial fermentation efficiency by increasing cell density, stability, and metabolic activity and have been successfully applied to the continuous production of many small-molecule chemicals. However, the continuous production of proteins by biofilms has been less studied. This study used secretory human epidermal growth factor (hEGF) as a representative product to evaluate and optimize biofilm-based continuous protein production. First, by deleting the protease and overexpressing eight key genes involved in protein secretion in Saccharomyces cerevisiae, the yield of hEGF was improved by 82.6% from 77.4 to 141.3 mg/L in shake flasks. Subsequently, the flocculation genes FLO11 and ALS3 were introduced to facilitate the establishment of a biofilm-based continuous immobilization fermentation model. The optimal strain SIC-ALS3-PDI1 produced 583.8 mg/L of hEGF, with a productivity of 4.9 mg/L/h during traditional free-cell fermentation, while it produced an average of 300.0 mg/L of hEGF in 10 continuous batches of biofilm-based fermentation, with a productivity of 6.3 mg/L/h. Although the hEGF production in biofilms was lower than that in free-cell fermentation, biofilm fermentation demonstrated greater productivity, with the advantage of not requiring seed culture for each batch of fermentation. This study provided a valuable reference for the biofilm-based production of other peptides.